CHOP Chemotherapy don Lymphoma

CHOP ne sunan da aka rage don hade da magunguna daban-daban. CHOP yana daya daga cikin haɗin magungunan da ake amfani dasu don lymphoma ba Hodgkin, ko NHL . Ana amfani da CHOP ga wasu nau'o'in mawuyacin hali kamar NHL maras kyau . Ya ƙunshi magunguna guda hudu: cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), vincristine (Oncovin) da prednisone.

Ana kuma haɗawa da CHOP tare da rituximab a tsarin R-CHOP .

Ana amfani da kwayoyi guda uku na tsarin cututtukan chemotherapy na CHOP a matsayin baƙuka ko infusions na veins a rana guda, yayin da an dauki ka'idoji a matsayin kwayoyi na kwana biyar. Mafi yawancin, ana ba da tsarin da ake kira R-CHOP a cikin makonni 3 na mako guda don 6-8.

An bayar da kwayoyi a cikin shirin CHOP na magance kwayoyin cutar kanjani a hanyoyi daban-daban. Lokacin da ake amfani da cyclophosphamide a matsayin ciwon daji na chemotherapy a cikin CHOP, yana aiki ta hanyar jinkirin ko tsayar da ciwon ciwon daji a jikinka. Zai iya samun mummunan lalacewa ta hanyar cewa yana rinjayar hanzari rarraba kwayoyin jikinsu a jiki wadanda suke da lafiya, kamar su wadanda suke haifar da gashi da wadanda ke cikin rufin gut-don haka gashin gashi da kuma bayyanar cututtuka na iya yiwuwa sakamakon illa.

Doxorubicin yana a cikin magungunan magungunan da ake kira anthracyclines, kuma yana aiki da jinkirin ko dakatar da ci gaban kwayoyin cutar ciwon daji.

Vincristine yayi aiki don hana ciwon daji daga duplication, a wani ɓangare ta hanyar kai hare-hare na tubes da kwayoyin halitta ke amfani da su don raba da raba. Kwayoyin ciwon daji sun fi sauki zuwa chemotherapy fiye da kwayoyin halitta, amma chemotherapy yana da tasiri a jikin kwayoyin halitta, wanda ya haifar da bayanan tasiri.

Hanyar Lymphomas tare da CHOP + Rituximab

Cyclophosphamide, doxorubicin, vincristine, da prednisone (CHOP), sun kasance mafi mahimmancin farfadowa na shekarun da suka wuce don marasa lafiya da kewayar lymphoma mai ƙwayar B-cell (DLBCL). Mafi yawan marasa lafiya tare da DLBCL za a iya warkewa tare da tsarin rituximab + cyclophosphamide, doxorubicin, vincristine, da prednisone (R-CHOP), duk da haka, sakamakon ba shi da kyau ga wadanda basu da kyau akan wannan tsarin.

Ana amfani da kwayoyin cutar ta CHOP ga yawancin nau'o'in ƙwayoyin lymphomas wadanda ba na Hodgkin, ciki har da T-cell Lymphoma na angioimmunobio, da lymphoma T-cell. Tsarin R-CHOP ya zama misali don magance mummunan hali, Stage I da Stage II na Cikin NHL da kuma m, wanda bai dace da Stage II / III / IV babba NHL ba.

Gudanarwa da Gudanarwa

Adriamycin yawanci ana ba da farko kamar yadda zai iya cutar da jini. Yana da mahimmanci ka gaya wa muminin jiko idan ka ji zafi ko ciwo a shafin yanar gizon . A wannan rana, za a ba ku magunguna guda biyu masu zuwa, Cytoxan da Vincristine.

Gidan asibitin zai bayar da shawara cewa kana da direba don kai ka gida bayan kowace magani. Kuna iya ganin canji a cikin launi na fitsari daga launi mai launi na Adriamycin na 'yan kwanaki bayan jiyya.

Hanyoyin Kasuwanci

> Sources:

> Sehn LH, Gascoyne RD. Kaddamar da babban lymphoma na B-cell: sakamako mai mahimmanci a cikin mahallin kwayoyin halitta da ilimin halitta. Jinin jini. 2015; 125 (1): 22-32.

> Matsaloli na Yanayin Cyclophosphamide, Doxorubicin, Vincristine, da Prednisone (CHOP), Cibiyar Cancer ta Duniya, Nuwamba 27, 2013.

> Magunguna marasa lafiya na Lymphoma-marasa lafiya (PDQ®), Cibiyar Cancer ta Kasa, Janairu 15, 2016.